PDB18 COMPARISON OF RESOURCES UTILIZATION (RU)AND COST IN DRUG NAVE TYPE 2 DIABETES (T2D) PATIENTS TREATED WITH ROSIGLITAZONE (RSG)VS. SULFONYLUREA (SU) MONOTHERAPY
May 1, 2008, 00:00
10.1016/S1098-3015(10)70706-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)70706-3/fulltext
Title :
PDB18 COMPARISON OF RESOURCES UTILIZATION (RU)AND COST IN DRUG NAVE TYPE 2 DIABETES (T2D) PATIENTS TREATED WITH ROSIGLITAZONE (RSG)VS. SULFONYLUREA (SU) MONOTHERAPY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70706-3&doi=10.1016/S1098-3015(10)70706-3
First page :
Section Title :
Open access? :
No
Section Order :
447